Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin

Abid Hussain*, Venkatesh Kairamkonda, David Richard Jenkins

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

Daptomycin is licensed for the management of Staphylococcus aureus infections in adults, including those caused by meticillin-resistant S. aureus (MRSA). Few data exist on paediatric use or dose guidance in neonates. We report the case of a neonate with MRSA bacteraemia successfully managed with daptomycin. Dose requirements were substantially higher than those recommended for adults.

Original languageEnglish
Pages (from-to)381-383
Number of pages3
JournalJournal of Medical Microbiology
Volume60
Issue number3
DOIs
Publication statusPublished - Mar 2011
Externally publishedYes

Fingerprint

Dive into the research topics of 'Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin'. Together they form a unique fingerprint.

Cite this